SideROS

SideROS
Area Bio Tech
Creation date January 2019
Development stage

Presentation

Supported by CNRS Innovation, SideROS was created in 2019 to develop functional therapies for the treatment of resistant cancers or cancers at risk of recurrence. Winner of the iLAB 2019 national competition.


Its first molecule, Ironomycin, resulting from the work of Raphaël Rodriguez (Chemistry and Cancer Biology team), is based on the specific metabolism of iron in resistant cancer cells to induce cell death, thus drastically limiting recurrence.

See also